Related Experiment Video
Updated: Nov 4, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016
Akesh Thomas1, Sajin Karakattu1, Jeanette Cagle1
1Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.
Abstract:
Introduction Pleural mesothelioma constitutes about 80% of all mesotheliomas. The peak incidence of malignant mesothelioma estimated using the cancer registries was in early 1990 to 2000 in the United States. The disease is primarily associated with asbestos exposure. The latency period between asbestos exposure and the development of malignant pleural mesothelioma (MPM) can range anywhere from 15 to 60 years. Asbestos exposure was peaked during the industrial revolution and World War II due to military and shipyard exposures. It is often difficult for the pathologist to distinguish different histological subtypes; due to the disease's rarity and the inadequate tissue sample obtained. There is no available data on the difference in epidemiology of different subtypes of MPM. Surveillance Epidemiology and End Results (SEER), cancer incidence data include population-based registries covering approximately 34.6% of the U.S. population. Here in our study, we analyze malignant pleural mesothelioma epidemiology in the United States, emphasizing different histological subtypes. Methods SEER data from 2000 to 2016 was used in our study. The primary site of cancer is selected as pleura, and malignant behavior only is selected as the filter. Data were analyzed using the SEER stat program. Overall epidemiology of MPM and epidemiology of epithelioid, fibrous, and biphasic histological subtypes were analyzed separately. We used annual percentage change (APC) to evaluate the trend in the epidemiology of MPM. Results summary A total of 11,857 cases of MPM were included in the primary cohort from the SEER 18 registry from 2000 to 2016. The total prevalence of MPM was highest in 2009 and was lowest in 2016. The APC in MPM incidence during this period is -2.0. After removing 5,989 cases with non-specified histology during the same period, the APC for each histological type is -0.7 for fibrous type, 1.8 for epithelioid type, and 2.9 for biphasic type. Out of 17 regional registries included in the study, the greatest statistically significant change in APC was seen in the Hawaiian registry -4.1. In contrast, the lowest statistically significant difference was seen in Seattle (Puget Sound) registry -1.7. The APC in the incidence of MPM among males during the study period was -2.4 while that of females was -0.9. The Iowa registry showed a statistically significant increase in APC of the epithelioid malignant mesothelioma with a statistically insignificant reduction in the overall MPM APC. Conclusion The overall incidence of MPM in the United States is declining, while the data showed an increase in the incidence of epithelioid and biphasic histological subtypes. The authors believe that these conflicting results can be attributed to improved histological diagnosis and improved biopsy techniques.
Insights
The overall incidence of malignant pleural mesothelioma (MPM) is decreasing in the U.S., but epithelioid and biphasic subtypes are increasing, possibly due to better diagnostic methods.
Area of Science:
- Epidemiology
- Oncology
- Public Health
Background:
- Malignant pleural mesothelioma (MPM) is primarily linked to asbestos exposure, with a long latency period.
- Distinguishing MPM histological subtypes can be challenging due to rarity and sample limitations.
- Epidemiological data on MPM subtypes is scarce.
Purpose of the Study:
- To analyze the epidemiology of malignant pleural mesothelioma (MPM) in the United States from 2000-2016.
- To investigate trends in MPM incidence across different histological subtypes.
- To identify regional variations in MPM epidemiology.
Main Methods:
- Utilized Surveillance Epidemiology and End Results (SEER) data from 2000-2016.
- Filtered data for primary site: pleura, and malignant behavior.
- Analyzed overall MPM epidemiology and specific subtypes (epithelioid, fibrous, biphasic) using Annual Percentage Change (APC).
Main Results:
- Overall MPM incidence shows a declining trend (APC: -2.0).
- Incidence of epithelioid (APC: 1.8) and biphasic (APC: 2.9) MPM subtypes increased, while fibrous (APC: -0.7) decreased.
- Significant regional variations observed, with Hawaii showing a marked decrease (APC: -4.1) and Seattle a smaller decrease (APC: -1.7).
Conclusions:
- The declining overall MPM incidence contrasts with an increasing trend in epithelioid and biphasic subtypes.
- Improved histological diagnosis and biopsy techniques may explain these seemingly conflicting findings.
- Further research into subtype-specific epidemiology is warranted.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleura of the Lungs
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...

